3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
244
Squamous Cell Carcinoma of Head and Neck
137
Melanoma
136
Parkinson Disease 4, Autosomal Dominant Lewy Body
119
Neoplasm Metastasis
105
Triple Negative Breast Neoplasms
96
Neoplasms
90
Lung Neoplasms
89
Breast Neoplasms
79
Colorectal Neoplasms
71
Carcinoma, Renal Cell
69
Head and Neck Neoplasms
59
Urinary Bladder Neoplasms
51
Stomach Neoplasms
49
Ovarian Neoplasms
46
Carcinoma, Transitional Cell
46
Endometrial Neoplasms
45
Pancreatic Neoplasms
35
Carcinoma, Hepatocellular
35
Uterine Cervical Neoplasms
34
Esophageal Neoplasms
27
Prostatic Neoplasms
26
Carcinoma
26
Recurrence
25
Carcinoma, Squamous Cell
25
Sarcoma
24
Brain Neoplasms
23
Glioblastoma
22
Cholangiocarcinoma
20
Hodgkin Disease
19
Interventions
Cyclophosphamide
8
ibrutinib
5
fludarabine phosphate
5
fludarabine
5
pirtobrutinib
4
Mesna
4
obinutuzumab
3
acalabrutinib
3
Mycophenolic Acid
3
Melphalan
3
venetoclax
2
Whole-Body Irradiation
2
Tacrolimus
2
Rituximab
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Busulfan
2
Bone Marrow Transplantation
2
ARQ531
2
ricolinostat
1
idelalisib
1
idecabtagene vicleucel
1
Vincristine
1
Stem Cell Transplantation
1
Rabeprazole
1
Prednisone
1
Leukapheresis
1
Itraconazole
1
Filgrastim
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, B-Cell
×
pembrolizumab
×
1 year
×
Clear all
No trials found.